News – Page 10 – Endpoints News

Exclusive: Can AI replace animal testing? A new biotech launches to find out

3 weeks ago

GSK’s checkpoint blocker Jemperli cures biomarker-driven rectal cancer

3 weeks ago

Keytruda around head and neck cancer surgery cuts chance of disease coming back

3 weeks ago

Revolution Medicines' KRAS drug shows potential in early cut of lung cancer data

3 weeks ago

J&J reports durability data for bladder cancer 'pretzel' drug after FDA filing

4 weeks ago

Earnings season is upon us; Makary on rare disease; Startup is first to inject CRISPR in the brain; and more

4 weeks ago

FDA chief Makary talks expediting drug approvals, RIFs and the abortion pill

4 weeks ago

AbbVie commits $10B to expand US footprint with the threat of tariffs ahead

4 weeks ago

Amgen invests $900M to expand Ohio biomanufacturing

4 weeks ago

Compounding pharmacies dealt a blow in fight over end of semaglutide shortage

4 weeks ago

RFK Jr. touts CMS program testing new ways to pay for sickle cell disease treatment

4 weeks ago

Akeso shares new data suggesting it can beat Keytruda on survival, wins China approval

4 weeks ago

Hoping to turn CD47 around with Keytruda combo, ALX Oncology reports two Phase 2 failures

4 weeks ago

New fund will pressure flailing biotechs, as investor frustration boils over

4 weeks ago

Lilly asks EU regulator to revisit Kisunla; CHMP recommends PTC's PKU drug

4 weeks ago

AbbVie's immunology franchise remains a powerhouse, as Skyrizi, Rinvoq combine for $5B

4 weeks ago

Paul Stoffels on retiring from Galapagos; Boehringer Ingelheim switches up leadership

4 weeks ago

Merck KGaA closes in on SpringWorks deal at $3.5B price point

4 weeks ago

Gilead's strong HIV business balances out low Covid and cancer drug sales

4 weeks ago

Caribou lays off 32% of staff, cuts lupus cell therapy program before first patient

4 weeks ago

Merck is ‘well-positioned’ on Keytruda ahead of threatened pharma tariffs, CEO says

4 weeks ago

Only two-thirds of FDA-approved biosimilars have launched, report finds

4 weeks ago

Drugmakers see a substantial, but manageable, hit to business from tariffs. But the worst may lie ahead

4 weeks ago

Cassidy urges congressional reforms to 340B drug discount program after investigation

4 weeks ago

First page Previous page 7 8 91011 12 13 Next page Last page